03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Gonzalo Olmedo-Saura: no photograph is held, so the academic plate is shown instead.
Academic
Gonzalo Olmedo-Saura
Researcher, Movement Disorders Research Group, Institut de Recerca Sant Pau; first author of the study
1
Nov 2026to date
1
press citation on 1 topic since 10 Nov 2026 · last quoted 10 Nov 2026
02 Quoted on · 1 of 29 topics
Gonzalo Olmedo-Saura: key facts
- Kind of voice
- Academic
- Role
- Researcher, Movement Disorders Research Group, Institut de Recerca Sant Pau; first author of the study
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 10 Nov 2026
04 The signal · where Gonzalo Olmedo-Saura sits on rare diseases
Ranked 49= of 100 voices quoted in the press on rare diseases, level with 51 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)9
- 2Dr Harrison CarterAcademicDirector of Screening at NHS England8
- 3=
Prof Dame Sue HillRegulatorChief Scientific Officer for England and Senior Responsible Officer for Genomics, NHS England7 - 49=Talal NsouliAcademicGeorgetown University, Washington DC; lead researcher on the first EoE study1
- 49=Eleanor ThomasAcademicMD, PhD, assistant professor of neurology at Emory University School of Medicine and co-principal investigator of the study1
- 49=Gonzalo Olmedo-SauraAcademicResearcher, Movement Disorders Research Group, Institut de Recerca Sant Pau; first author of the study1
- 49=Ianthe PitoutClinicianDr, molecular geneticist, Murdoch University Personalised Medicine Centre1
- 49=Jesús Pérez-PérezAcademicResearcher, Movement Disorders Research Group, Institut de Recerca Sant Pau; first author of the study1
Showing the leaders and the ranks around 49=, of 100 voices · See every voice on the topic →
05 On the record · press
What Gonzalo Olmedo-Saura has said
By outlet · linked articles
- technologynetworks.com1
Where Gonzalo Olmedo-Saura has been quoted
- 01Blood and CSF Biomarker May Detect Huntington's Disease Activity Earliertechnologynetworks.com · 10 Nov 2026
Verbatim
“The results indicate that NfL can provide complementary information about disease activity in individuals who do not yet show clinical manifestations. This is relevant for research into early treatments because we need to identify more precisely the biological condition of each participant.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Coventry tot's heartbreaking health battle after 'extremely rare' diagnosiscoventrytelegraph.net
- Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdlereuters.com
- 'Immoral lottery' - Mum's plea after losing daughter to rare diseasethewestmorlandgazette.co.uk
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.